Trially AI

Trially AI

Private
Kansas City, MissouriHealthcare & Life Scienceshttps://trially.ai

Last Round

Seed

Sep 16, 2025

Total Funding Raised

$4.7M

Company Overview

Trially AI is an AI-first clinical trial recruitment platform that aims to solve delays in patient recruitment. The company provides a HIPAA-compliant platform that uses Large Language Model (LLM) agents to analyze unstructured medical data to match, connect, and enroll patients into suitable clinical trials. This technology is designed for physicians, research sites, Contract Research Organizations (CROs), and pharmaceutical sponsors to accelerate the trial process. The platform includes features like 'Trially Match' for patient identification, 'Trially Connect' for AI-driven outreach and pre-screening, and 'Trially Intelligence' for feasibility analytics. The company was founded in 2023 and is headquartered in Kansas City, Missouri. In September 2025, Trially AI announced it had raised $4.7 million in a seed funding round led by Flyover Capital.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Medical AI, Patient Engagement, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

clinical trial recruitmentAI for clinical trialspatient recruitment platformpatient-trial matchingHIPAA-compliant AIpatient pre-screeningAI agentspatient engagement platformunstructured data analysisEHR integrationtrial feasibility analysislife sciences AImedical AIcontract research organizationCROhealth techclinical trial management systemCTMS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trially AI Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Trially AI Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 16, 2025

Key People

Founding team and executive leadership

Ramon Prieto

CTO Co-Founder

Founding Team

Kyle McAllister

CEO Cofounder

Founding Team

Trially AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2025

    Launched Margo, an agentic AI solution for clinical trial enrollment.

  • Sep 16, 2025

    $4.7M raised in Seed round.

Trially AI Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Trially AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Trially AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersKansas City, Missouri
Employee Range12
Year Founded2023
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.